SARAH SNIK: Open Payments
NPI 1588349476 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $124 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $78 |
| ABBVIE INC. | 2 | $42 |
| Corium, LLC | 1 | $26 |
| Bausch Health US, LLC | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: TRINTELLIX, VRAYLAR, Azstarys, APLENZIN, INGREZZA, Jornay PM, CAPLYTA.
Industry payments across VA — which companies pay providers there.
